Immuno-expression analysis of VEGF and CD34 related to histological types of mandibular ameloblastoma
Downloads
Background: Increased expression of vascular endothelial growth factor (VEGF) and cluster of difference 34 (CD34) in ameloblastoma has been noted. Both proteins are markers of angiogenesis that play a role in supporting the growth of ameloblastoma. The existence of histopathological types of ameloblastoma allows for differences in behavioral and growth characteristics. Purpose: To evaluate the differences and correlation of VEGF and CD34 expression in histological types of ameloblastoma. Methods: This laboratory cross-sectional study uses total sampling from histological slides of mandibular ameloblastoma. Two observers manually quantified the immunohistochemical expression. The comparative data were analyzed statistically with the Kruskal–Wallis test (p < 0.05), while the correlative data were analyzed with Spearman’s rho (p<0.01). Results: 32 samples were obtained according to the inclusion criteria. The Kruskal–Wallis test showed significant differences in VEGF expression (p = 0.003) and CD34 expression (p = 0.026). The pairwise comparison test showed that VEGF expression in follicular ameloblastoma significantly differed from plexiform (p = 0.001) and combination (p = 0.002). The pairwise comparison test for CD34 expression showed a significant difference between follicular and combination ameloblastoma (p = 0.007). Spearman’s rho test showed a positive correlation (p = 0.001, r = 0.565) between markers. Conclusion: Follicular ameloblastoma expressed higher VEGF than plexiform and combination ameloblastoma. Follicular ameloblastoma expressed higher CD34 than combination types. CD34 expression is associated with VEGF in histological types of ameloblastoma.
Downloads
Masthan KMK, Anitha N, Krupaa J, Manikkam S. Ameloblastoma. J Pharm Bioallied Sci. 2015; 7(Suppl 1): S167-70. doi: https://doi.org/10.4103/0975-7406.155891
Lay E, Kentjono WA. Bilateral ramus mandibulectomy with plate reconstruction in ameloblastic carcinoma patient. Dent J. 2022; 55(3): 174–8. doi: https://doi.org/10.20473/j.djmkg.v55.i3.p174-178
Rachman A, Djulaeha E, Kresnoadi U. Aesthethic and masticatory rehabilitation on post mandibular resection with combination of hollow obturator and hybrid prosthesis. Dent J (Majalah Kedokt Gigi). 2009; 42(2): 76. doi: https://doi.org/10.20473/j.djmkg.v42.i2.p76-81
Guan P, Wong SF, Lim JQ, Ng CCY, Soong PL, Sim CQX, Ong CK, Rajasegaran V, Myint SS, Lee JY, Tan HK, Iyer NG, Soo KC, Teh BT, Tay ABG. Mutational signatures in mandibular ameloblastoma correlate with smoking. J Dent Res. 2019; 98(6): 652–8. doi: https://doi.org/10.1177/0022034519837248
Athallandi KA, Aulia WS, Gofur ARP, Winias S. Combination of dental follicle stem cells and nanocomposite fibrous scaffold for regeneration of post operative bone defect Ameloblastoma. Biochem Cell Arch. 2020; 20: 3005–9. doi: https://doi.org/10.35124/bca.2020.20.S1.3005
Effiom OA, Ogundana OM, Akinshipo AO, Akintoye SO. Ameloblastoma: current etiopathological concepts and management. Oral Dis. 2018; 24(3): 307–16. doi: https://doi.org/10.1111/odi.12646
Nugroho WS, Kamadjaja SS, Pramono C, Kamadjaja DB. Histological pattern of ameloblastoma in Affiliated Hospitals of Oral and Maxillofacial Surgery Department Faculty of Dental Medicine Airlangga University. Malaysian J Med Heal Sci. 2022; 18(Supp 6): 1–5. web: https://medic.upm.edu.my/upload/dokumen/2022042811223801_MJMHS_0601.pdf
Gupta K, Chaturvedi TP, Gupta J, Agrawal R. Cell proliferation proteins and aggressiveness of histological variants of ameloblastoma and keratocystic odontogenic tumor. Biotech Histochem. 2019; 94(5): 348–51. doi: https://doi.org/10.1080/10520295.2019.1571226
Widodo HB, Saptiwulan A, Hirawan H, Prihastuti CC, Wardana T. Immunohistochemical differential expression of p16 proteins in follicular type and plexiform type ameloblastoma. Dent J. 2022; 55(3): 137–41. doi: https://doi.org/10.20473/J.DJMKG.V55.I3.P137-141
Hanahan D, Weinberg RA. Biological Hallmarks of Cancer. In: Holland‐Frei cancer medicine. Wiley; 2022. p. 1–10. doi: https://doi.org/10.1002/9781119000822.hfcm002.pub2
Agus P. Prognostic value of molecular markers of oral pre-malignant and malignant lesions. Dent J (Majalah Kedokt Gigi). 2009; 42(2): 104. doi: https://doi.org/10.20473/j.djmkg.v42.i2.p104-108
Rahman SB, Sadat SA, Haider IA, Ahmed M. Analysis of histological variants of ameloblastomas of jaws in relation to their clinical presentations. J Bangladesh Coll Physicians Surg. 2017; 35(2): 61–7. doi: https://doi.org/10.3329/jbcps.v35i2.33365
Goh YC, Siriwardena BSMS, Tilakaratne WM. Association of clinicopathological factors and treatment modalities in the recurrence of ameloblastoma: Analysis of 624 cases. J Oral Pathol Med. 2021; 50(9): 927–36. doi: https://doi.org/10.1111/jop.13228
Arima Y, Oikawa M, Shimizu Y, Echigo S, Takahashi T, Kumamoto H. Immunohistochemical assessment of hypoxia-inducible factor-1α (HIF-1α) and carbonic anhydrase IX (CA IX) in ameloblastomas. J Oral Maxillofac Surgery, Med Pathol. 2018; 30(3): 294–300. doi: https://doi.org/10.1016/j.ajoms.2017.10.002
Zhafirah R, Nur Aida A, Hirawan H, Wardana T. Wound healing induces VEGF expression stimulated by forest honey in palatoplasty Sprague Dawley. Dent J. 2023; 56(1): 48–52. doi: https://doi.org/10.20473/j.djmkg.v56.i1.p48-52
Gupta B, Chandra S, Singh A, Sah K, Raj V, Gupta V. The role of vascular endothelial growth factor in proliferation of odontogenic cysts and tumors: An immunohistochemical study. Dent Res J (Isfahan). 2016; 13(3): 256–63. doi: https://doi.org/10.4103/1735-3327.182187
Jiang X, Wang J, Deng X, Xiong F, Zhang S, Gong Z, Li X, Cao K, Deng H, He Y, Liao Q, Xiang B, Zhou M, Guo C, Zeng Z, Li G, Li X, Xiong W. The role of microenvironment in tumor angiogenesis. J Exp Clin Cancer Res. 2020; 39(1): 204. doi: https://doi.org/10.1186/s13046-020-01709-5
Rizal MB, Munadziroh E, Kriswandini IL. The increase of VEGF expressions and new blood vessels formation in Wistar rats induced with post-tooth extraction sponge amnion. Dent J (Majalah Kedokt Gigi). 2018; 51(1): 1–4. doi: https://doi.org/10.20473/J.DJMKG.V51.I1.P1-4
Sularsih. The pore size of chitosan-Aloe vera scaffold and its effect on VEGF expressions and woven alveolar bone healing of tooth extraction of Cavia cobaya. Dent J. 2020; 53(3): 115–21. doi: https://doi.org/10.20473/j.djmkg.v53.i3.p115-121
ArabSheibani M, Seifi S, Salehinejad J, Bijani A. Expression of CD34, VEGFR3 and eosinophil density in selected odontogenic tumors- a pilot study. J oral Biol craniofacial Res. 2020; 10(1): 367–71. doi: https://doi.org/10.1016/j.jobcr.2019.09.003
Hassan WA, Ibrahim R. Expression of CD117, CD34, and VEGF proteins in progression from endometrial hyperplasia to endometrioid carcinoma. Int J Clin Exp Pathol. 2020; 13(8): 2115–22. pubmed: https://pubmed.ncbi.nlm.nih.gov/32922608/
Maschio LB, Madallozo BB, Capellasso BAM, Jardim BV, Moschetta MG, Jampietro J, Soares FA, Zuccari DAP de C. Immunohistochemical investigation of the angiogenic proteins VEGF, HIF-1α and CD34 in invasive ductal carcinoma of the breast. Acta Histochem. 2014; 116(1): 148–57. doi: https://doi.org/10.1016/j.acthis.2013.06.005
Palta A, Kaur M, Tahlan A, Dimri K. Evaluation of angiogenesis in multiple myeloma by VEGF immunoexpression and microvessel density. J Lab Physicians. 2020; 12(1): 38–43. doi: https://doi.org/10.1055/s-0040-1714933
Guntarno NC, Rahaju AS, Kurniasari N. The role of MMP-9 and VEGF in the invasion state of bladder urothelial carcinoma. Indones Biomed J. 2021; 13(1): 61–7. doi: https://doi.org/10.18585/inabj.v13i1.1348
Kumamoto H, Ohki K, Ooya K. Association between vascular endothelial growth factor (VEGF) expression and tumor angiogenesis in ameloblastomas. J Oral Pathol Med. 2002; 31(1): 28–34. doi: https://doi.org/10.1046/j.0904-2512.2001.10061.x
Ghai S. Ameloblastoma: an updated narrative review of an enigmatic tumor. Cureus. 2022; 14(8): e27734. doi: https://doi.org/10.7759/cureus.27734
Ferreira SJ, De Araújo Lima EDN, De Andrade ALDL, Do Carmo AF, Freitas RDA, Galvão HC. Immunoexpression of VEGF, TGF-ß, and MMP-9 in solid ameloblastoma and adenomatoid odontogenic tumor. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014; 117(2): e210. doi: https://doi.org/10.1016/j.oooo.2013.12.315
Bhuyan L, Nishat R, Behura SS, Mahapatra N, Kumar H. Insight into the molecular pathogenesis of odontogenic lesions. J oral Biosci. 2021; 63(1): 35–44. doi: https://doi.org/10.1016/j.job.2020.12.001
Lu Y, Zhang X, Li X. Molecular biology exploration and targeted therapy strategy of Ameloblastoma. Arch Oral Biol. 2022; 140: 105454. doi: https://doi.org/10.1016/j.archoralbio.2022.105454
Jain A, Gupta S, Sharma P. Role of hypoxia-inducible proteins in ameloblastoma: A review. J Oral Maxillofac Surgery, Med Pathol. 2023; 35(3): 296–301. doi: https://doi.org/10.1016/j.ajoms.2022.11.005
Pereira T, Dodal S, Tamgadge A, Bhalerao S, Tamgadge S. Quantitative evaluation of microvessel density using CD34 in clinical variants of ameloblastoma: An immunohistochemical study. J Oral Maxillofac Pathol. 2016; 20(1): 51–8. doi: https://doi.org/10.4103/0973-029X.180929
Setyawan B, Widiatuti MG, Rahmat M. Ekspresi Syndecan-1, Matriks Metalloproteinase-2 dan IL-1α pada Ameloblastoma Multikistik (Penelitian Retrospektif Analitik di RSUP. Dr. Sardjito Tahun 2010 - 2014). J Ked Gi. 2016; 7(2): 26–33. web: https://jurnal.ugm.ac.id/jkg/article/view/27847
Dineshkumar T, Priyadharsini N, Gnanaselvi UP, Sathishkumar S, Srikanth RP, Nagarathinam AE. Evaluation and comparison of vascular endothelial growth factor expression between ameloblastoma and keratocystic odontogenic tumor. J Int oral Heal JIOH. 2015; 7(1): 48–52. pubmed: https://pubmed.ncbi.nlm.nih.gov/25709368/
Schlüter A, Weller P, Kanaan O, Nel I, Heusgen L, Höing B, Haßkamp P, Zander S, Mandapathil M, Dominas N, Arnolds J, Stuck BA, Lang S, Bankfalvi A, Brandau S. CD31 and VEGF are prognostic biomarkers in early-stage, but not in late-stage, laryngeal squamous cell carcinoma. BMC Cancer. 2018; 18(1): 272. doi: https://doi.org/10.1186/s12885-018-4180-5
Duffaud F. Role of TKI for metastatic osteogenic sarcoma. Curr Treat Options Oncol. 2020; 21(8): 65. doi: https://doi.org/10.1007/s11864-020-00760-w
Naito H, Iba T, Takakura N. Mechanisms of new blood-vessel formation and proliferative heterogeneity of endothelial cells. Int Immunol. 2020; 32(5): 295–305. doi: https://doi.org/10.1093/intimm/dxaa008
Jamshidi S, Zargaran M, Baghaei F, Shojaei S, Zare Mahmoodabadi R, Dehghan A, Moghimbeigi A. An immunohistochemical survey to evaluate the expression of CD105 and CD34 in ameloblastoma and odontogenic keratocyst. J Dent (Shiraz, Iran). 2014; 15(4): 192–8. pubmed: https://pubmed.ncbi.nlm.nih.gov/25469359/
Maryam HS, Alamgir, Hadi S, Sehrish. Quantitative evaluation of mean vascular density using cd34 as immunohistochemical marker in variants of ameloblastoma. Int J Pathol. 2022; 20(3): 121–6. web: https://www.jpathology.com/index.php/OJS/article/view/786
Schulze AB, Schmidt LH, Heitkötter B, Huss S, Mohr M, Marra A, Hillejan L, Görlich D, Barth PJ, Rehkämper J, Evers G. Prognostic impact of CD34 and SMA in cancer‐associated fibroblasts in stage I–III NSCLC. Thorac Cancer. 2020; 11(1): 120–9. doi: https://doi.org/10.1111/1759-7714.13248
Kong X, Guan J, Ma W, Li Y, Xing B, Yang Y, Wang Y, Gao J, Wei J, Yao Y, Xu Z, Dou W, Lian W, Su C, Ren Z, Wang R. CD34 over-expression is associated with gliomas’ higher WHO grade. Medicine (Baltimore). 2016; 95(7): e2830. doi: https://doi.org/10.1097/MD.0000000000002830
Sherlin HJ, Natesan A, Ram P, Ramani P, Thiruvenkadam C. Immunohistochemical profiling of Ameloblastomas using cytokeratin, vimentin, smooth muscle actin, CD34 and S100. Ann Maxillofac Surg. 2013; 3(1): 51–7. doi: https://doi.org/10.4103/2231-0746.110084
Maryam HS, Hadi S, Hanan F, Saif H, Alamgir. Assessment of angiogenesis in ameloblastoma: a comparison base on patient age. Int J Clin Stud Med Case Reports. 2022; 20(5): 1–6. doi: https://doi.org/10.46998/IJCMCR.2022.20.000496
Copyright (c) 2025 Dental Journal
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
- Every manuscript submitted to must observe the policy and terms set by the Dental Journal (Majalah Kedokteran Gigi).
- Publication rights to manuscript content published by the Dental Journal (Majalah Kedokteran Gigi) is owned by the journal with the consent and approval of the author(s) concerned.
- Full texts of electronically published manuscripts can be accessed free of charge and used according to the license shown below.
- The Dental Journal (Majalah Kedokteran Gigi) is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License
